📰 Initial Results News
Page 5 - Initial Results News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Initial Results. Real-time updates on events, politics, business and more.
November 23, 2021
Phase III POLARIX trial showed Polivy plus R-CHP was the first treatment in two decades to significantly improve outcomes in newly diagnosed diffuse large B-cell lymphoma (DLBCL) versus the standard of
November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
September 22, 2021
Wie viele Stimmen erhielten die Grünen bei den letzten Bundestagswahlen in Wiehl? Wie hat die CDU in den 90er Jahren abgeschnitten? Wie waren die anfänglichen Ergebnisse der AfD? Wir haben uns die Stimmabgaben aller Bundestagswahlen seit der Wiedervereinigung 1990 angesehen. Hier finden Sie die Ergebnisse.
September 22, 2021
Wie viele Stimmen erhielten die Grünen bei den letzten Bundestagswahlen in Wassenberg? Wie hat die CDU in den 90er Jahren abgeschnitten? Wie waren die anfänglichen Ergebnisse der AfD? Wir haben uns die Stimmabgaben aller Bundestagswahlen seit der Wiedervereinigung 1990 angesehen. Hier finden Sie die Ergebnisse.
May 19, 2021
MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2021 -Zandelisib, an investigational agent, +/- rituximab demonstrated 82% overall response rate in patients with relapsed or refractory (r/r) follicular lymphoma (FL) who had progression of disease within 24 months of first line chemoimmunotherapy (POD24); overall response rate of 93% in non-POD24- -An 8% discontinuation rate was observed in the combined study population-...
January 18, 2021
E-Mail Targeted neuromodulation tailored to individual patients distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinsons disease. Now, scientists at UC San Franciscos Dolby Family Center for Mood Disorders have demonstrated a novel personalized neuromodulation approach that -- at least in one patient -- was able to provide relief from symptoms of severe treatment-resistant depression within minutes. The approach is being d...
December 22, 2020
Tocvan Completes Phase One Drilling and Provides Update Calgary, Alberta – TheNewswire December 22, 2020. TOCVAN Ventures Corp. is pleased to announce the completion of its maiden drill program at the Pilar Gold-Silver Project in Sonora, Mexico. A total of 1,505 meters of reverse circulation drilling was completed in nine drill holes. All samples have been submitted to the lab in Hermosillo, results are expected in early 2021 and will be released in batches as they are … (TheNewswire) Cal...